新型分类系统下剖宫产瘢痕妊娠的治疗结局:一项回顾性队列研究
本研究回顾性分析单中心2010年10月至2022年12月84例剖宫产瘢痕妊娠(CSP)患者,按Jordans等分类分为1、2、3型(分别60、17、7例),比较各型治疗结局。药物治疗和手术治疗总体成功率分别为70%和97%;1型和2型多经创伤更小的药物治疗成功,3型多需手术切除CSP及剖宫产瘢痕憩室。作者认为该分类易于复制和临床实施,需前瞻性研究证实。
要点
- Jordans等CSP分类将病例分为1、2、3型,本组分别占71.4%、20.2%、8.3%。
- 药物治疗总体成功率70%,手术治疗总体成功率97%。
- 1型和2型CSP更多经创伤更小的药物治疗获得成功,3型多需手术切除CSP及剖宫产瘢痕憩室。
核心结论
- Jordans等发表的CSP分类易于复制且便于临床实施;1型和2型CSP较高比例经创伤更小的药物治疗成功且成功率高,而3型CSP多数需手术切除CSP及剖宫产瘢痕憩室才能成功去除。
研究设计与样本
- 回顾性研究,纳入2010年10月至2022年12月单家三级中心诊断为CSP的84例女性,依据Jordans等发表的分类将超声记录分为3型并比较各型治疗结局。
诊断标准与关键数值
- 按Jordans等发表的分类将CSP超声记录分为1型、2型、3型,本组分别为60例(71.4%)、17例(20.2%)、7例(8.3%)。
- 药物治疗总体成功率为70%,手术治疗总体成功率为97%。
临床应用与阅片要点
- 本组47例(55.9%)接受甲氨蝶呤治疗,22例(26.2%)接受不切除剖宫产瘢痕憩室的CSP手术治疗,11例(13.1%)接受切除CSP及剖宫产瘢痕憩室的手术。
- 4例期待治疗并继续妊娠,其中3例妊娠超过34周且新生儿结局良好。
局限性
- 原文结论指出需要前瞻性研究来证实这些发现并进一步验证该命名系统的临床实用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether the new classification system published by Jordans et al for cesarean scar pregnancy (CSP) can guide management and treatment outcomes.
METHODS: A retrospective study of women diagnosed with CSP from October 2010 to December 2022 in a single tertiary center was performed. Sonographic records of these women were classified into three types according to the classification published by Jordans et al. Treatment outcomes were compared across each type of CSP.
RESULTS: The study included a total of 84 women, where 60 (71.4%), 17 (20.2%), and 7 (8.3%) of them were categorized into Type 1, 2, and 3 CSP, respectively. A total of 47 (55.9%) women were managed with methotrexate, 22 (26.2%) underwent surgical management of the CSP without removal of the Cesarean section (CS) niche, and 11 (13.1%) underwent surgery to remove the CSP and the CS niche. Overall treatment success rates for medical management and surgical management were 70 and 97%, respectively. Four women were managed expectantly and continued their pregnancies, among which three carried beyond 34 weeks and had good neonatal outcomes.
CONCLUSIONS: The classification as published by Jordans et al is easily replicable and readily implemented clinically. Our findings show that a higher proportion of Type 1 and Type 2 CSP were treated successfully by a less invasive medical approach with a high success rate, whereas most Type 3 CSP required surgical resection to successfully remove the CSP and the CS niche. Prospective studies are required to confirm these findings and further validate the clinical utility of this nomenclature system.
引用
- Yung KK, Lee LLL, Choy KW, et al. Treatment Outcomes of Cesarean Scar Pregnancy Under a Novel Classification System: A Retrospective Cohort Study. J Ultrasound Med. 2024. PMID: 38634558. doi:10.1002/jum.16464
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。